Serum levels of sCD23, interleukin-10 and interferon-γ in patients with coeliac disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 9-10, 1997, Pages 685-689

  Bansal, A S ^a   Bruce, J ^a   Thomson, A ^b   Kerlin, P ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Coeliac disease; IFN ; IL 10; Soluble CD23

Indexed keywords

CD23 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ARTICLE; BLOOD LEVEL; CELIAC DISEASE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM BIOPSY; ENTERITIS; FEMALE; GLUTEN FREE DIET; HELPER CELL; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; INTESTINE VILLUS ATROPHY; MALE; MUCOSAL IMMUNITY; PRIORITY JOURNAL;

EID: 0030834588     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00535.x     Document Type: Article

References (29)

1. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('Celiac Sprue'). Gastroenterology 1992; 102: 330-57.
2. MacDonald TT. The role of activated T lymphocytes in gastrointestinal disease. Clin. Exp. Imm. 1990; 20: 247-52.
3. Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PJ. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 1994; 35: 1037-41.
4. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or ThO profile dominated by interferon gamma. Gut 1995; 37: 766-76.
5. Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 1995; 36: 874-9.
6. Kontakou M, Przemioslo RT, Sturgess RP et al. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 1995; 37: 52-7.
7. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol. Today. 1992; 13: 198-200.
8. Delespesse G, Suter U, Mossalayi D et al. Expression, structure and function of the CD23 antigen. Adv. Immunol. 1991; 49: 149-91.
9. Gordon J. CD23 and B cell activation. Clin. Exp. Allergy 1992; 22: 199-204.
10. Bansal AS, Roberts T, Hay EM, Kay R, Pumphrey RSH, Wilson PB. Soluble CD23 levels are elevated in the serum of patients with primary Sjögrens syndrome and SLE. Clin. Exp. Immunol. 1992; 89: 452-55.
11. Bansal AS, Ollier W, Marsh MN, Pumphrey RSH, Wilson PB. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology 1993; 79: 285-89.
12. Burke GW, Cirocco R, Roth D et al. Activated cytokine pattern in hepatorenal syndrome: Fall in levels after successful orthotopic liver transplantation. Transplantat. Proc. 1993; 25: 1876-77.
13. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434-44.
14. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin 10. Curr. Opin. Immunol. 1992; 4: 314-22.
15. Ralph P, Nakoinz I, Sampson-Johannes A et al. IL10, T lymphocyte inhibitor of human blood cell production of IL1 and tumour necrosis factor. J. Immunol. 1992; 148: 808-14.
16. Kucharzik T, Stoll R, Lügering N, Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin. Exp. Immunol. 1995; 101: 452-456.
17. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Imm. 1995; 101: 428-135.
18. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin 10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74.
19. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2 and interferon-gammasecreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78: 127-31.
20. Fais S, Capobianchi MR, Silvestri M, Mercuri F, Pallone F, Dianzani F. Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. J. Interferon Res. 1994; 14: 235-8.
21. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 1992; 98: 279-85.
22. Sasaki T, Hiwatashi N, Yamazaki H, Noguchi M, Toypota T. The role of interferon in the pathogenesis of Crohn's disease. Gastroenterol Jpn. 1992; 27: 29-35.
23. Bansal AS, Cochrane S, Haeney MR, Bhavnani M, Pumphrey RSH, Wilson PB. Serum soluble CD23 in conditions with hypogammaglobulinaemia and varying B cell numbers. Clin. Exp. Immunol. 1994; 97: 239-41.
24. Anon. Clinicopathological conference: A case of Crohn's disease in a patient with treated adult coeliac disease. BMJ 1967; 2: 222-6.
25. Euler A, Ament M. Celiac sprue and Crohn's disease: an association causing severe growth retardation. Gastroenterology 1977; 72: 729-31.
26. Shah A, Mayberry J, Williams G, Holt P, Loft D, Rhodes J. Epidemiological survey of coeliac disease and inflammatory bowel disease in first-degree relatives of coeliac patients. QJM 1990; 74: 283-88.
27. Cottone M, Cappello M, Puleo A, Cipolla C, Filippazzo M. Familial association of Crohn's and coeliac diseases. Lancet 1989; 338: 8658.
28. Cush JJ, Splawski JB, Thomas R et al. Elevated interleukin-10 in patients with rheumatoid arthritis. Arthritis Rheumatism 1995; 38: 96-104.
29. Duchmann R, Kaiser I, Hermann E et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 1995; 102: 448-55.